Key result
Researchers successfully generate human iPSC lines from five individuals with MYBPC3 variants to model HCM.
Why the study?
HCM is often caused by variants in MYBPC3, leading the authors to generate human induced pluripotent stem cell lines to serve as disease models to investigate HCM pathogenesis.
Answers are grounded in this paper and cite their sources.
The successful generation of iPSC lines from patients with Dutch MYBPC3 founder variants provides a valuable in vitro model for investigating the pathogenesis of hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is often caused by pathogenic or likely pathogenic variants, of which 30-50 % involve a variant in the gene encoding cardiac myosin-binding protein-C (MYBPC3). We generated human induced pluripotent stem cell lines from five individuals from two families carrying a pathogenic Dutch MYBPC3 founder variant: c.2373insG (n = 2) and c.2827C > T (n = 3), with highly variable disease expression. Peripheral blood mononuclear cells were reprogrammed using episomal plasmids. All cell lines express pluripotent markers, exhibit a normal karyotype, and could differentiate into derivatives of each germ layers in vitro. These cell lines can serve as disease model to investigate HCM pathogenesis.
No takes yet. Share an insight, caveat, or question.
Dolder et al. (2025) studied Hypertrophic cardiomyopathy (n=5). Generation of induced pluripotent stem cell lines was evaluated on Generation and characterization of iPSC lines. Human induced pluripotent stem cell lines were successfully generated from five individuals carrying pathogenic Dutch MYBPC3 founder variants to serve as a disease model for hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: